Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Sergei Boichuk"'
Autor:
Sergei Boichuk, Firyuza Bikinieva, Elena Valeeva, Pavel Dunaev, Maria Vasileva, Pavel Kopnin, Ekaterina Mikheeva, Tatyana Ivoilova, Ilshat Mustafin, Aigul Galembikova
Publikováno v:
Diagnostics, Vol 13, Iss 16, p 2646 (2023)
Aim: To establish a p53-negative osteosarcoma (OS) SaOS-2 cellular subline exhibiting resistance to specific chemotherapeutic agents, including topoisomerase II inhibitors, taxanes, and vinca alkaloids. Methods: The OS subline exhibiting resistance t
Externí odkaz:
https://doaj.org/article/de40a3537f9c47499e69fb4ae8f2a9d0
Autor:
Sergei Boichuk, Kirill Syuzov, Firuza Bikinieva, Aigul Galembikova, Svetlana Zykova, Ksenia Gankova, Sergei Igidov, Nazim Igidov
Publikováno v:
Molecules, Vol 27, Iss 9, p 2873 (2022)
Despite the tubulin-binding agents (TBAs) that are widely used in the clinic for cancer therapy, tumor resistance to TBAs (both inherited and acquired) significantly impairs their effectiveness, thereby decreasing overall survival (OS) and progressio
Externí odkaz:
https://doaj.org/article/202a850ca35b4a9b829ddec444e7c870
Autor:
Sergei Boichuk, Pavel Dunaev, Ilshat Mustafin, Shinjit Mani, Kirill Syuzov, Elena Valeeva, Firuza Bikinieva, Aigul Galembikova
Publikováno v:
Biomedicines, Vol 10, Iss 3, p 601 (2022)
The microtubule-targeting agents (MTAs) are well-known chemotherapeutic agents commonly used for therapy of a broad spectrum of human malignancies, exhibiting epithelial origin, including breast, lung, and prostate cancer. Despite the impressive resp
Externí odkaz:
https://doaj.org/article/982aa04a1252421fb9c4eed7c2236797
Autor:
Sergei Boichuk, Aigul Galembikova, Kirill Syuzov, Pavel Dunaev, Firuza Bikinieva, Aida Aukhadieva, Svetlana Zykova, Nazim Igidov, Ksenia Gankova, Maria Novikova, Pavel Kopnin
Publikováno v:
Molecules, Vol 26, Iss 19, p 5780 (2021)
Microtubule targeting agents (MTAs) that interfere with the dynamic state of the mitotic spindle are well-known and effective chemotherapeutic agents. These agents interrupt the microtubule network via polymerization or depolymerization, halting the
Externí odkaz:
https://doaj.org/article/167c747a06524f98aae5997be3d1ab89
Autor:
Sergei Boichuk, Aigul Galembikova, Firuza Bikinieva, Pavel Dunaev, Aida Aukhadieva, Kirill Syuzov, Svetlana Zykova, Nazim Igidov, Alexander Ksenofontov, Pavel Bocharov
Publikováno v:
Molecules, Vol 26, Iss 3, p 616 (2021)
Microtubules are known as the most attractive molecular targets for anti-cancer drugs. However, the number of serious limitations of the microtubule targeting agents (MTAs) including poor bioavailability, adverse effects (e.g., systemic and neural to
Externí odkaz:
https://doaj.org/article/a9ef501aa1d042889535eae6c41d658c
Autor:
Galina Guseva, Elena Antina, Mikhail Berezin, Svetlana Lisovskaya, Roman Pavelyev, Airat Kayumov, Olga Lodochnikova, Daut Islamov, Konstantin Usachev, Sergei Boichuk, Liliya Nikitina
Publikováno v:
Molecules, Vol 25, Iss 19, p 4541 (2020)
This study focuses on the behavior of a new fluorescent marker for labeling individual biomolecules and staining cell organelles developed on a meso-substituted BODIPY platform. Boron(III) complex with meso-4-methoxycarbonylpropylsubstituted 3,3’,5
Externí odkaz:
https://doaj.org/article/41e5882006f54af5a1f5304f42335894
Autor:
Sergei Boichuk, Aigul Galembikova, Pavel Dunaev, Ekaterina Micheeva, Elena Valeeva, Maria Novikova, Natalya Khromova, Pavel Kopnin
Publikováno v:
Molecules, Vol 23, Iss 10, p 2643 (2018)
Dysregulation of the fibroblast growth factor (FGF)/fibroblast growth factor receptor (FGFR) signaling pathway is frequently observed in multiple human malignancies, and thus, therapeutic strategies targeting FGFs and FGFRs in human cancer are being
Externí odkaz:
https://doaj.org/article/57fcc37f994348e583c28a8cad12385e
Autor:
Sergei Boichuk, Aigul Galembikova, Pavel Dunaev, Elena Valeeva, Elena Shagimardanova, Oleg Gusev, Svetlana Khaiboullina
Publikováno v:
Molecules, Vol 22, Iss 12, p 2152 (2017)
The fact that most gastrointestinal stromal tumors (GISTs) acquire resistance to imatinib (IM)-based targeted therapy remains the main driving force to identify novel molecular targets that are capable to increase GISTs sensitivity to the current the
Externí odkaz:
https://doaj.org/article/5959249216c941679da6a31b7616ec55
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e25814 (2011)
The promyelocytic leukemia protein (PML) is a tumor suppressor critical for formation of nuclear bodies (NBs) performing important functions in transcription, apoptosis, DNA repair and antiviral responses. Earlier studies demonstrated that simian vir
Externí odkaz:
https://doaj.org/article/a094f2db62b14bc69662843f91dfbfe9
Autor:
Anette Duensing, James A. DeCaprio, Maria Debiec-Rychter, Patrick Schöffski, Danushka S. Seneviratne, Nina Korzeniewski, Keith R. Mehalek, Agnieszka Wozniak, James P. Zewe, Julianne L. Baron, Larisa Litovchick, Kathleen R. Makielski, Joshua A. Parry, Sergei Boichuk
PDF file - 70K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a03f4aabc93d141472d2f7cbc0d689
https://doi.org/10.1158/0008-5472.22402647.v1
https://doi.org/10.1158/0008-5472.22402647.v1
